Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cidara Therapeutics, Inc. | 130,087 | reported | 30 Sept 2024 | tx 17+1,377,938−116,041 |
| Elicio Therapeutics, Inc. | 47,900 | reported | 02 Feb 2026 | tx 3+263,524 |
| BRAINSTORM CELL THERAPEUTICS INC | 11,600 | reported | 30 Dec 2020 | tx 5+236,600−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 24,000 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 47,900 | 0.00 USD | deriv |
| 15 Apr 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 191,624 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 130,087 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 108,750 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 217,500 | 0.00 USD | deriv |
| 11 Mar 2024 | SALE | Cidara Therapeutics, Inc. | 18,931 | 0.67 USD | |
| 27 Mar 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 90,000 | 0.00 USD | |
| 27 Mar 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |
| 13 Mar 2023 | SALE | Cidara Therapeutics, Inc. | 6,648 | 1.53 USD | |
| 19 Sept 2022 | SALE | Cidara Therapeutics, Inc. | 15,642 | 0.77 USD | |
| 15 Sept 2022 | EXERCISE | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 15 Sept 2022 | EXERCISE | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 66,001 | 0.00 USD | |
| 31 Mar 2022 | TAX_WITHHOLDING | Cidara Therapeutics, Inc. | 24,820 | 0.83 USD | |
| 31 Mar 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 51,250 | 0.00 USD | |
| 31 Mar 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 102,500 | 0.00 USD | deriv |
| 12 Nov 2021 | PURCHASE | Cidara Therapeutics, Inc. | 20,000 | 1.54 USD | first after silence |
| 01 Sept 2021 | GRANT_AWARD | Cidara Therapeutics, Inc. | 311,850 | 0.00 USD | deriv |
| 01 Sept 2021 | GRANT_AWARD | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 30 Dec 2020 | TAX_WITHHOLDING | BRAINSTORM CELL THERAPEUTICS INC | 25,000 | 4.64 USD | |
| 24 Dec 2019 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 11,600 | 3.96 USD | |
| 06 Sept 2019 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 25,000 | 0.00 USD | |
| 06 Sept 2019 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 100,000 | 0.00 USD | deriv |
| 06 Sept 2019 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 100,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 12 Nov 2021.